Ep. 38 - Peter Pitts

In this episode of The Business of America podcast, host Jerry Rogers sits down with Peter Pitts — former FDA Associate Commissioner and president of the Center for Medicine in the Public Interest — for a hard-hitting conversation on America’s drug pricing crisis and President Trump’s recent executive order introducing Most Favored Nation (MFN) pricing.

Pitts outlines why the executive order might backfire, what’s really driving high drug costs (hint: pharmacy benefit managers and insurance middlemen), and why reference pricing from Europe won’t fix America's access or innovation problems. They explore why reforms like 340B and market-based trade negotiations are more effective paths forward.

This episode cuts through the political noise with real policy insights on how to lower drug prices without sacrificing access or innovation.